Cognitive Behavioral Therapy
CBT can help someone understand connections between thoughts, emotions, triggers, and cocaine use and develop alternative coping strategies.
Cocaine addiction, clinically referred to as cocaine use disorder, is a treatable substance use disorder involving a pattern of cocaine use that causes significant impairment or distress.
Treatment differs from opioid or alcohol treatment in one important way: there is currently no FDA-approved medication specifically for cocaine use disorder. Behavioral treatments are therefore central to care. Current clinical guidance identifies contingency management as particularly important, while cognitive behavioral therapy, community reinforcement approaches, motivational strategies, and other behavioral services may also be used. SAMHSA
Treatment can take place in outpatient programs, residential settings, intensive outpatient care, partial hospitalization, mental health programs, or a combination of settings depending on the person's needs.
Cocaine addiction is primarily treated with behavioral interventions and individualized addiction care.
Contingency management, cognitive behavioral therapy, community reinforcement approaches, motivational interventions, counseling, mental health treatment, and recovery support may all be part of care.
Some people receive treatment while living at home. Others may benefit from residential treatment because of psychiatric symptoms, other substance use, an unstable recovery environment, or the need for more structure.
There is currently no FDA-approved medication specifically for cocaine use disorder, although clinicians may use medications for co-occurring medical or psychiatric conditions and research into pharmacological treatments continues. SAMHSA
Cocaine is a stimulant that affects the brain and central nervous system.
Not everyone who has used cocaine has cocaine use disorder.
The disorder involves a broader pattern in which cocaine use becomes difficult to control and causes meaningful problems in health, relationships, responsibilities, safety, finances, or other areas of life.
A person may use more cocaine than intended, repeatedly try to stop without success, experience strong cravings, spend substantial amounts of time using or recovering from cocaine, or continue using despite recognizing serious consequences.
Professional assessment considers the overall pattern rather than making a diagnosis based on one symptom.
The latest 2025 National Survey on Drug Use and Health estimated that approximately 4.9 million people aged 12 or older used cocaine during the past year, representing about 1.7% of the U.S. civilian, noninstitutionalized population in that age range. SAMHSA
Cocaine-related overdose also remains an important public-health concern. Final CDC mortality data show that 21,945 U.S. overdose deaths in 2024 involved cocaine. The age-adjusted cocaine-involved overdose death rate declined from 8.6 per 100,000 in 2023 to 6.3 in 2024, but the number remained substantial. Deaths can involve more than one drug, so a cocaine-involved death does not necessarily mean cocaine was the only substance present. CDC
Treatment should begin with an assessment rather than automatically placing every person into the same rehab program.
A treatment professional may ask about cocaine use, frequency and pattern of use, route of use, cravings, previous attempts to stop, other substances, physical health, mental health, medications, previous treatment, housing, support systems, and current safety concerns.
The assessment may also consider cardiovascular symptoms and psychiatric concerns because stimulant use can affect both physical and mental health. Current stimulant-treatment guidance recommends assessing co-occurring medical, psychiatric, and other substance use conditions rather than treating cocaine use in isolation. ASAM
Readers who want a broader explanation of the treatment journey can continue to the how rehab works guide.
Cocaine withdrawal is different from alcohol, benzodiazepine, or opioid withdrawal.
People stopping regular cocaine use may experience strong cravings, fatigue, depressed mood, irritability, anxiety, sleep disturbance, difficulty concentrating, or reduced ability to feel pleasure.
Symptoms and their intensity vary.
One especially important issue is mental health. ASAM/AAAP guidance recommends monitoring psychiatric symptoms during stimulant withdrawal because depression, psychosis, trauma-related symptoms, or suicidal thoughts can emerge or worsen as stimulant intoxication resolves. ASAM/AAAP
Because of this, someone with severe depression, suicidal thoughts, psychosis, chest pain, loss of consciousness, or another urgent medical or psychiatric problem needs professional evaluation.
Not everyone with cocaine use disorder needs a separate medical detox facility.
Treatment may begin in outpatient care when the person can be treated safely in the community. Other people may require a more supervised setting because of psychiatric symptoms, cardiovascular problems, polysubstance use, severe impairment, or other clinical concerns.
Withdrawal support may focus on sleep, nutrition, monitoring, psychiatric symptoms, cravings, and safety.
Completing a withdrawal period does not treat the full cocaine use disorder.
The larger treatment plan still needs to address cocaine-use patterns, triggers, mental health, relationships, recovery environment, and strategies for remaining engaged in care.
The site's drug detox programs guide can provide broader information about withdrawal-management services.
Contingency management, often shortened to CM, is a behavioral treatment that uses structured positive reinforcement to encourage treatment goals.
For example, a program may provide incentives for behaviors such as attending treatment or meeting verified treatment targets.
This is not simply “paying someone not to use drugs.” It is a structured behavioral intervention based on reinforcement principles.
The ASAM/AAAP stimulant-use-disorder guideline identifies contingency management as a primary component of treatment for stimulant use disorder, and ASAM describes it as the current standard of care with particularly strong evidence for stimulant disorders. ASAM
In 2025, SAMHSA also updated federal grant guidance to make evidence-based contingency-management programs easier to implement under certain federally funded programs. SAMHSA
Contingency management does not have to be the only treatment service.
CBT can help someone understand connections between thoughts, emotions, triggers, and cocaine use and develop alternative coping strategies.
This approach focuses on changing environmental and social factors so that healthy activities and relationships become more rewarding than continued substance use.
Motivational approaches can help people explore uncertainty about changing their cocaine use and strengthen engagement in treatment.
The Matrix Model, a structured behavioral approach originally developed for stimulant treatment, may also be used in some programs.
Current ASAM/AAAP guidance recognizes contingency management, CBT, community reinforcement approaches, and the Matrix Model among behavioral approaches used for stimulant use disorder. ASAM/AAAP
There is currently no FDA-approved medication specifically for treating cocaine use disorder. SAMHSA
This makes cocaine treatment different from opioid use disorder, where medications such as buprenorphine and methadone are established treatment options, or alcohol use disorder, where several medications are FDA-approved.
That does not mean medication is never involved in cocaine treatment.
Someone may need medication for depression, anxiety, sleep problems, another substance use disorder, or another medical condition.
Current stimulant-use-disorder guidelines also discuss certain off-label pharmacological approaches that trained addiction specialists may consider in selected circumstances, but these are individualized clinical decisions and should not be presented as universally approved cocaine medications. ASAM/AAAP
Cocaine addiction does not automatically require inpatient rehab.
Residential treatment may be appropriate when someone needs a highly structured environment, has significant psychiatric or medical concerns, is using multiple substances, has repeatedly struggled in less intensive treatment, or does not have a stable recovery environment.
The inpatient drug rehab guide can provide deeper information about residential care.
Outpatient treatment allows someone to continue living outside the facility while attending scheduled treatment.
Cocaine treatment can work well in outpatient settings, particularly because behavioral approaches such as contingency management and CBT can be delivered through community programs.
Depending on intensity, outpatient care may range from routine counseling to IOP or PHP services.
The outpatient drug rehab guide explains these levels in more detail.
Depression, anxiety, trauma-related symptoms, psychosis, and other mental health concerns can occur alongside cocaine use disorder.
Cocaine use can also worsen psychiatric symptoms or make diagnosis more complicated.
For example, stimulant intoxication or withdrawal can influence mood, anxiety, paranoia, sleep, or thinking.
Treatment should therefore assess both substance use and mental health rather than assuming every psychiatric symptom is unrelated.
The site's dual diagnosis treatment guide provides a deeper explanation of coordinated mental-health and addiction care.
Today's cocaine treatment also needs to consider possible opioid exposure.
Current stimulant-treatment guidance specifically notes concern about contamination of stimulants with high-potency synthetic opioids such as fentanyl. ASAM
Someone may therefore be exposed to an opioid even when they intended to use only cocaine.
This matters during assessment, overdose-prevention planning, and treatment for polysubstance use.
A person using cocaine from the unregulated drug supply should know about opioid-overdose risk and naloxone availability.
Readers who need more information about opioid exposure can continue to the site's fentanyl addiction treatment guide.
Cocaine can contribute to serious medical emergencies, including cardiovascular and neurological complications.
Chest pain, loss of consciousness, severe agitation, seizures, stroke-like symptoms, or severe confusion require urgent medical evaluation.
Because fentanyl or another opioid may also be present in an illicit drug supply, naloxone can be important when opioid exposure is possible.
If someone develops severe suicidal thoughts, psychosis, or another mental health crisis in the United States, call or text 988, or call 911 when there is immediate danger.
A return to cocaine use should be taken seriously, but it does not automatically mean treatment has failed.
Current ASAM guidance advises treatment programs not to make abstinence an automatic condition for entering or remaining in care and recommends avoiding administrative discharge solely because substance use recurs. ASAM
Instead, the treatment plan may need reassessment.
The team may need to consider treatment intensity, contingency-management participation, mental health symptoms, housing, social environment, other substance use, or barriers that make treatment difficult to attend.
Keeping someone engaged in care can be an important treatment goal in itself.
There is no universal cocaine rehab length.
Someone may receive intensive treatment for a period and then transition to standard outpatient care.
Another person may begin in outpatient treatment and remain there while progress is monitored.
The ASAM Criteria emphasizes treatment duration based on a person's progress and evolving needs rather than assigning the same predetermined length to everyone. ASAM
Continuing support may include therapy, recovery coaching, peer support, mental health care, case management, housing assistance, or other services depending on the person's needs.
A quality program should be able to explain which behavioral treatments it actually provides, rather than simply advertising generic “individual and group therapy.”
Ask whether the program offers CM or coordinates another evidence-based stimulant treatment.
Ask which specific behavioral approaches are actually provided.
Ask how depression, anxiety, psychosis, trauma, and other psychiatric concerns are assessed.
Ask how fentanyl exposure and use of other substances are addressed.
Ask what happens after the initial treatment phase and how long-term engagement is supported.
SAMHSA recommends looking for licensed programs that use evidence-based practices and provide support for mental health, medical needs, family needs, and longer-term recovery. SAMHSA
Readers comparing the broader stimulant-treatment landscape can also continue to the stimulant addiction treatment guide.
Insurance may cover substance use disorder treatment, but specific benefits vary by plan and treatment provider.
Coverage can depend on whether care is residential or outpatient, network status, authorization requirements, deductible, copayments, coinsurance, and the clinical services being provided.
Readers can use the site's verify insurance for rehab resource to explore potential benefits and the how much rehab costs guide for broader cost information.
Yes. Cocaine use disorder can be treated with evidence-based behavioral interventions, appropriate levels of addiction care, mental health treatment, recovery support, and other individualized services.
Contingency management has particularly strong evidence and is identified by current ASAM/AAAP guidance as a primary treatment component for stimulant use disorder. ASAM
There is currently no FDA-approved medication specifically for cocaine use disorder. SAMHSA
Withdrawal can involve fatigue, depressed mood, irritability, anxiety, sleep changes, problems concentrating, reduced pleasure, and strong cravings. Psychiatric symptoms and suicide risk require particular attention. NIDA Data Share
No. Many people receive cocaine treatment in outpatient programs. The appropriate level of care depends on medical, psychiatric, substance-use, environmental, and safety needs.
There is no FDA-approved medication specifically for cocaine withdrawal or cocaine use disorder. Clinical care may focus on monitoring, rest, psychiatric safety, symptom management, and transition into ongoing behavioral treatment.
CBT is one of the behavioral approaches supported in current stimulant-treatment guidance and may help people identify triggers and develop coping strategies. ASAM/AAAP
Illicit stimulants can be contaminated with high-potency synthetic opioids such as fentanyl, creating additional overdose risk. ASAM
Treatment should be reassessed rather than automatically stopped. Current ASAM guidance recommends keeping nonabstinent patients engaged in care whenever possible. ASAM
You do not need to know in advance whether outpatient treatment, residential rehab, contingency management, mental health care, or another treatment approach is the right starting point.
Treatment can be explored based on cocaine use, physical and mental health, other substances, living environment, previous treatment, location, and insurance circumstances.
This page provides general educational information about cocaine use disorder, stimulant withdrawal, behavioral treatment, rehab, and overdose prevention.
It is not medical advice, diagnosis, or an individualized treatment recommendation.
Questions about cocaine use, withdrawal, mental health symptoms, medications, pregnancy, or treatment decisions should be discussed with appropriately qualified healthcare professionals.
For a mental health, suicide, or substance-use crisis, call or text 988.